췌장암 세포주 MIA PaCa-2에서 황백 물 추출물에 의한 Apoptosis 유도 및 작용기전

키워드

참고문헌 (72)

1. Bond-Smith, G., "Pancreatic adenocarcinoma", BMJ, 344, pp.2476~ (2012)
2. Hariharan, D., "Analysis of mortality rates for pancreatic cancer across the world", HPB, 10(1), pp.58~62 (2008)
3. Song, K. J., "The problems of surgical management in pancreatic cancer", J Korean Surg Soc, 38, pp.583~594 (1990)
4. Nawrocki, S. T., "Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis", Cancer Res, 65(24), pp.11658~11666 (2005)
5. Nawrocki, S. T., "Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in humun pancreatic cancer cells", Cancer Res, 65(24), pp.11510~11519 (2005)
6. Ernst, E., "The prevalence of complementary", alternative medicine in cancer : a systematic review, 1998, pp.83, 777~782
7. 보건복지가족부, "우리나라 암 환자가 이용하는 대체보완요법 분류 및 비용 분석" (2005), 보건복지가족부
8. Katsumasa Kuroi, "Current status of health outcome assessment of medical treatment in breast cancer", breast cancer, 14(1), pp.74~80 (2007)
9. Johnson, J. R., "Food and Drug Administration requirement for approval of new anticancer drugs", Cancer Treat Rep, 69, pp.1155~1157 (1985)
10. 최철민, "간, 담도, 췌장의 진행암으로 한방병원에 내원한 환자의 삶의 질(FACT-G)에 대한 분석", 대한한의학회지, 29(4), pp.30~38 (2008), 대한한의학회
11. Surh, Y.J., "Cancer chemoprevention with dietary phytochemicals", Nat. Rev. Cancer, 3, pp.768~780 (2003)
12. Lopez-Lazaro, M., "Flavonoids as anticancer agents: structure-activity relationship study", Curr. Med. Chem. Anticancer. Agents, 2, pp.691~714 (2002)
13. 全國韓醫科大學 本草學敎室, "본초학", pp.201~223 (2007), 영림사
14. 신민교, "임상본초학", pp.367~407 (2000), 영림사
15. 안세영, "본초정의", pp.113~117 (2009), 청홍
16. Park, E. K., "Antiinflammatory effects of a combined herbal preparation (RAH13) of Phellodendron amurense and Coptis chinensis in animal models of inflammation", Phytother Res, 21, pp.746~750 (2007)
17. Zhang, J., "Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum-induced rat model of neurodegenerative disease", Saudi Med J, 30, pp.760~766 (2009)
18. Bhutada, P., "Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin induced diabetes", Behav Brain Res, 220, pp.30~41 (2011)
19. Ghosh, R., "Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management", Anticancer Res, 30(3), pp.857~865 (2010)
20. Muralimanoharan, S. B., "Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells", Prostate, 69(5), pp.494~504 (2009)
21. Nishida, S., "Induction of apoptosis in HL-60 cells treated with medicinal herbs", Am J Chin Med, 31(4), pp.551~562 (2003)
22. Jemal, A., "Cancer statistics", CA Cancer J Clin, 53, pp.5~26 (2003)
23. 보건복지가족부, "암등록통계" (2007), 보건복지가족부
24. 통계청, "사망원인계연보-인구동태신고 집계" (2006), 통계청
25. 정현철, "췌장암-항암치료가 필요한가", 대한내과학회지, pp.740~749 (1999)
26. 정성우, "췌장암의 치료 방법에 따른 생존 분석", 대한소화기학회지, 46(2), pp.120~128 (2005), 대한소화기학회
27. 강순호, "췌장암의 예후", 대한외과학회지, 64(4), pp.332~337 (2003), 대한외과학회
28. 송시영, "췌장암의 원인 및 발암기전", 대한소화기학회지, 51(2), pp.71~83 (2008), 대한소화기학회
29. 김동희, "항암제 및 방사선 부작용에 대한 한방요법", 동의병리학회지, 9(1), pp.239~263 (1994)
30. Chung, Y. T., "Cytotoxic effects of actinomycin D, adramycin and puromycin in the development stage of early mouse embryos", J. Wonkwang Medical Sci, 3, pp.13~34 (1987)
31. Surh, Y.J., "Cancer chemoprevention with dietary phytochemicals", Nat. Rev. Cancer, 3, pp.768~780 (2003)
32. Lopez-Lazaro, M., "Flavonoids as anticancer agents: structure-activity relationship study", Curr. Med. Chem. Anticancer. Agents, 2, pp.691~714 (2002)
33. 崔昇勳, "東醫腫瘍學", pp.19~100 (1995), 杏林出版社
34. 姜延良, "六味地黃湯防法 腫瘤的 害驗硏究", pp.471~474 (1983), 中醫雜志
35. 김한섭, "암의 치법 치방 및 치료약물에 관한 문헌적 고찰", 대한한의학회지, 10(1), pp.161~166 (1989)
36. 문미현, "인간 신경모세포종 세포주 LAN5에 대한 扶正抗癌湯의 항종양효과", 동의생리병리학회지, 20(6), pp.1548~1555 (2006), 대한동의병리학회
37. 배원식, "암의 한양방병용치료에 대한 보고", 대한한의학회지, 7(2), pp.53~57 (1986)
38. 박영순, "한방의 약리해설", pp.173~ (2002), 아카데미서적
39. 盛腸能, "重慶出版社", pp.538~541 (1994), 重慶出版社
40. 서정범, "黃柏 추출물이 대식세포의 면역단백질 생성에 미치는 영향" (2010), 경원대학교
41. 이문조, "황백 열수추출물의 항산화활성과 아질산염 소거작용에 관한 연구", 동의병리학회지, 13(1), pp.112~119 (1999)
42. 金義根, "黃柏의 腫瘍抑制 및 免疫活性에 관한 硏究", 대한한방부인과학회지, 15(1), pp.19~30 (2002), 대한한방부인과학회
43. 권영모, "황백이 사람 대장암 세포주 HCT116의 Apoptosis 유도 및 MMP-9 발현에 미치는 영향" (2007), 동국대학교
44. Wyllie, A. H, "Apoptosis;Cell death in tissue regulation", J Pathol, 153, pp.313~316 (1987)
45. Thompson, C. B, "Apoptosis in the pathogenesis and treatment of disease", Science, 267, pp.1456~1461 (1995)
46. Raff, M. C., "Programed cell death and the control of cell survival", Science, 262, pp.695~700 (1993)
47. Williams, G. T, "Programmed cell death : apoptosis and oncogenesis", Cell, 65, pp.1097~1098 (1991)
48. 김인경, "아포토시스와 종양성장억제", 대한의학협회지, 37, pp.1222~1229 (1994)
49. Kim, W.H., "Apoptosis and disease", Med Postgrad, 6(24), pp.275~288 (1996)
50. Amaravadi, R. K., "The roles of therapy-induced autophagy and necrosis in cancer treatment", Clin Cancer Res, 13(24), pp.7271~7279 (2007)
51. Searle, J., "Necrosis and apoptosis:distinct modes of cell death with fundamentally different significance", Pathol. Annu, 17, pp.229~259 (1982)
52. Cohen, J.J., "Apoptosis:the physiologic pathway of cell death", Hosp. Pract, 28, pp.35~43 (1993)
53. Zeng, H., "Apoptosis and Bcl-2 family proteins, taken to chronic obstructive pulmonary disease", Eur Rev Med Pharmacol Sci, 16(6), pp.711~727 (2012)
54. Aluyen, J. K., "Resveratrol: potential as anticancer agent", J Diet Suppl, 9(1), pp.45~56 (2012)
55. Wang, H., "Effect of NF-κB signaling on apoptosis in chronic inflammation-associated carcinogenesis", Curr Cancer Drug Targets, 10(6), pp.593~599 (2010)
56. Koopman, G., "Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis", Blood, 84, pp.1415~1420 (1994)
57. Manon van Engeland, "Reutelingsperger : A novel assy to measure loss of plasma membrane asymmetry during apoptosis of adherent cell in culture", Cytometry, 24, pp.131~138 (1996)
58. Sang-Gyung Kim, "Quantitation of the Early Apoptotic Cells Using Flow Cytometry", Korean J Clin Pathol, 9(1), pp.108~113 (1999)
59. Muñoz-Pinedo, C., "Signaling pathways that regulate life and cell death: evolution of apoptosis in the context of self-defense", Adv Exp Med Biol, 738, pp.124~143 (2012)
60. Ishikawa, K., "DNA damage-dependent cell cycle checkpoints and genomic stability", DNA Cell Biol, 25(7), pp.406~411 (2006)
61. Pardee, A.B., "G1 events and regulation of cell proliferation", Science, 246, pp.603~608 (1989)
62. Mishra, N. C., "Apoptosis: a mitochondrial perspective on cell death", Indian J Exp Biol, 43(1), pp.25~34 (2005)
63. Mita, M., "Novel apoptosis inducing agents in cancer therapy", Curr Probl Cancer, 29(1), pp.8~32 (2005)
64. Gruter, M.G., "caspases: Key players in programmed cell death", Curr Opin Struct Biol, 10, pp.649~655 (2000)
65. Reed, J.C., "Apoptosis and cancer: Strategies for integrating programmed cell death", Semin Hematol, 37, pp.9~16 (2000)
66. Mocarski, E. S., "Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways", Nat Rev Immunol, 12(2), pp.79~88 (2011)
67. Kaufmann, T., "Fas death receptor signalling: roles of Bid and XIAP", Cell Death Differ, 19(1), pp.42~50 (2012)
68. Cook, J. A., "oxidative stress, redox, and the tumor microenvironment", seminars radiat. oncol, 14, pp.259~266 (2004)
69. Halliwell, B., "Free radicals in biology and medicine" (1999), Oxford University Press
70. Ray, P. D., "Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling", Cell Signal, 24(5), pp.981~990 (2012)
71. Pelicanl, H., "ROS stress in cancer cells and theraputic implications. drug resist", updates, 7, pp.97~110
72. Valko, M., "Free radicals and antioxidants in normal physiological functions and human disease", Int. J. Biochem. Cell Biol, 39, pp.44~84 (2007)

관련 논문AI추천